Purchase Order 75F40120P00137

This is a $100,000.00 firm fixed price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to 3D Imaging Drug Design & Development LLC, a small business, to provide synthesis and delivery of DFNSH radiotracers to support the FDA's research efforts in imaging and drug development. The contract has a total small business set-aside designation and runs through October 31, 2023. 3D Imaging Drug Design & Development LLC is a limited liability company that...

This federal contract award is for the delivery of FLUORODEOXYGLUCOSE FDG 1-15MCI and SODIUM FLUORIDE (F-18 NAF) radiopharmaceuticals to the Defense Health Agency (DHA), a defense agency. The $22,440 firm-fixed-price contract was awarded to Sofie CO., doing business as IBA Molecular, a for-profit organization that specializes in the development, production, and delivery of molecular diagnostics and therapeutics, particularly radiopharmaceuticals and positron emission tomography (PET) imaging...

Nuclear Diagnostic Products, Inc. was awarded a two-year, firm fixed price delivery order valued at approximately $1.9 million by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA VHA VISN 2) to provide general radiopharmaceuticals. The contract has a period of performance starting February 22, 2021 through February 21, 2023, with all work to be conducted by the prime contractor at its facility located in Rockaway, New Jersey. No major...

Nuclear Diagnostic Products, Inc., a for-profit provider of radiopharmaceuticals, has been awarded a firm fixed-price delivery order contract valued at $249,981.40 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4. The contract is for the delivery of radiopharmaceuticals to support nuclear medicine imaging procedures, such as positron emission tomography (PET) scans, performed at VA medical facilities in Philadelphia, Pennsylvania. No...

This is a delivery order award to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., by the Defense Health Agency (DHA) for the radiopharmaceutical product PYLARIFY (piflufolastat F-18). PYLARIFY is a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The award, valued at $10,540.71, is a firm fixed price Blanket Purchase Agreement (BPA) call order, with an ultimate completion date of December 31,...

This is a Delivery Order awarded by the Department of Energy (DOE) Office of Science to Nuclear Medicine Solutions, Inc., a for-profit Subchapter S Corporation. The Delivery Order is for medical isotope calibration services in December 2017 under the DOE Medical Isotopes Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The Delivery Order has a Firm Fixed Price of $108,862.38 and a Completion Date of January 31, 2019. The Place of Performance is Ashburn, VA. This Delivery Order is not set...

This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 8 (VISN 8), a component of the U.S. Department of Veterans Affairs (VA), to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents, nuclear medicine supplies, and radiopharmaceutical products. The contract, valued at $362,242.50, is for the delivery of FDG 18 radiopharmaceuticals without a small business set-aside designation. Lantheus Medical Imaging holds two...

This delivery order (DE-DT0013341) was issued under the existing master contract DE-SC0017487 between the Department of Energy (DOE) Office of Science and the prime contractor, Global Isotopes, LLC (doing business as Zevacor Molecular). The purpose of this delivery order is to procure two deliveries of partially processed SR-82 radioisotope from Zevacor Molecular. The first delivery of 3,300 millicuries (mCi) is scheduled for June 16, and the second delivery of 4,400 mCi is scheduled for June...

This is a $71,400 firm fixed-price federal contract award to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract was awarded by the Defense Health Agency (DHA) for the delivery of the radiopharmaceutical product SOM2 NETSPOT GA68 INJECTION. This purchase order contract supports the DHA's procurement of specialized radiopharmaceuticals for use in medical diagnostic and therapeutic procedures,...

This delivery order, awarded under the Pharmaceuticals and Drugs Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9, is for $6,560.40 worth of DATSCAN nuclear isotope NDC 17156-0210-01 from Medi-Physics, Inc., a subsidiary of General Electric Company. The contract has no set-aside designation and requires completion by December 31, 2021. As a radiopharmaceutical used in nuclear medicine imaging procedures, this diagnostic agent...